Tag: Data4

Global International

BenevolentAI announces restructure and strategic focus

BenevolentAI, a clinical-stage AI-enabled drug discovery and development company, has published its strategic plan for a “new era in AI”. The company has outlined its focus to prioritise high-potential products to value inflection points, develop new products to capitalise on the “vast potential of AI”, and progress a proposed headcount reductions […]

Primary Care News

NHSE launches primary care digital and transformation lead development programme

NHS England has launched a new programme to support PCN digital and transformation leads with core skills to lead transformational change.   Through a twelve month development programme, digital and transformation lead ARRS roles will be supported with quality improvement, data and digital, managing transformation, and a peer community to share learnings. […]

News

Considerations for artificial intelligence and machine learning in drug development and manufacturing

The FDA has released a discussion paper designed to generate discussion about artificial intelligence and machine learning in drug development and manufacturing, entitled ‘Using Artificial Intelligence & Machine Learning in the Development of Drug & Biological Products’. The paper covers a number of key topics including current and potential uses […]

ICS

Dorset ICS plans integration and interoperability redesign

Dorset Integrated Care System has launched a discovery phase to review its current integration and interoperability landscape, with an aim to redesign its data architecture. The ICS is looking for the supplier market to support the review and develop a target architecture. It hopes to explore “an approach, using modern technologies […]

News

Yorkshire Imaging Collaborative opens AI funding competition

The Yorkshire Imaging Collaborative has launched an artificial intelligence funding competition, with an aim to improve patient safety, diagnostic accuracy and accelerate care pathways. It has been designed to “support operational clinical trials of existing radiology AI solutions which can be readily purchased off the shelf today”. Applications can bid […]